Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...

I was at a cancer meeting in Brisbane when the question about the culture of a community occurred to me. The meeting was well ...

CROs can contribute to site collaboration by also identifying and supporting non-academic institutions capable of conducting ...

Letter outlines Phase 3 timeline for PrimeC in ALS, provides update on Canadian regulatory pathway and strategic partnership discussions; Company optimistic about ongoing ...

Details of the presentation are as follows: Title: VERSATILE-003: A Phase 3, Randomized, Open-label Trial of PDS0101 and Pembrolizumab compared with Pembrolizumab for First-Line Treatment of Patients ...

From consumer products to clinical trials, anything that is designed without ... clinicaltrials.gov website might read the brief titles and summary descriptions and think, “I don’t know ...

Alterity Therapeutics (ATHE) announced that new presentations related to its Multiple System Atrophy program were delivered at the American ...

Guideline for Good Clinical Practice [iii] Friends of Cancer Research. Randomized and Single-Arm Trials. [vii] Global Pharmaceutical Industry: Overview & Success Factors, A closer look at ...

For media and investors only Joenja® is the first and only medicine specifically for APDS to be reimbursed within the NHS Recommended for adult and pediatric patients 12 years of age and older ...

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

Title: " Advancing Colorectal Cancer Research and Personalized Treatment through a CRC Platform Clinical Trial" Summary: The CRC platform trial will establish a collaborative, data-driven ...